CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. (CNSP) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cnsp · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.50
Consensus
$0.50
-89.8% upside
Low
$0.50
Median: $0.5 · Last Close: $4.92
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.84 | ↓ 1.78% |
1-day model range: $4.71–$4.97. Peak: $4.97 (-1.78%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · CNSP · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-09-12 | Maxim Group | Upgrade ↑ | Hold→Buy |
| 2025-03-25 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2021-02-02 | Brookline Capital | Maintains | Buy→Buy |
| 2020-08-24 | Ladenburg Thalmann | Maintains | Buy→Buy |
| 2019-12-04 | Benchmark | Maintains | Speculative Buy→Buy |
Wall Street analysts have recently issued updated ratings on CNS Pharmaceuticals, Inc. (CNSP) stock. Of the recent 5 rating actions, 1 were upgrades and 1 were downgrades. 4 analysts currently cover CNSP.
Analyst Recommendation Trends
CNSP analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$41M
↓ 46.5% YoY
Revenue Next Year
$50M
↑ 22.7% YoY
EPS This Year
$-1.65
EPS Next Year
$-1.66
↑ 0.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast CNSP EPS of $-1.65 for the current fiscal year, based on estimates from 1 analysts. The CNSP revenue forecast is $41M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CNSP stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CNSP price target is $0.50 (-89.8% upside), with an analyst consensus of Buy.
The CNSP short-term stock prediction for tomorrow is $4.84 (-1.78%).
CNS Pharmaceuticals, Inc. trades on NASDAQ under the ticker CNSP. The CNSP stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
CNSP forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month CNSP price target is $0.50, with a high forecast of $0.50 and a low of $0.50. The median price target is shown in the chart above when available. This implies -89.8% potential upside from the current price of $4.92.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.